A 40-year-old Human Resources Manager, Bisi, with uterine fibroids, delayed her treatment for over  four years for fear of ...

Although hysterectomy remains the most common procedure for treating fibroids and fibroids are the leading indication for ...

The presence of fibroids made it difficult for her ovaries to be seen and accessed for egg retrieval, resulting in fewer eggs ...

Uterine fibroids are a common condition that affects up to 80% of women in their lifetime. Nearly half of those women will experience symptoms that affect their quality of life and fertility, ...

In recent years, there has been an increasing focus on the contributory role of uterine fibroids to infertility. The prevalence of these tumors increases with age, which becomes significant as ...

Theramex has announced that the Scottish Medicine Consortium (SMC) has recommended Yselty® for the treatment of moderate to severe symptoms of uterine fibroids (UFs) aligned to the product indication ...

Theramex has announced that the Scottish Medicine Consortium (SMC) has recommended Yselty® for the treatment of moderate to severe symptoms of uterine fibroids (UFs) aligned to the product indication ...

A daily oral therapy for uterine fibroids has been recommended for NHS by NICE, providing a new option for around 30,000 women in England and Wales. Theramex's GnRH antagonist Yselty (linzagolix ...

offering another option to treatment with injectable GnRH drugs used for women with moderate to severe symptoms. Uterine fibroids are benign tumours that develop in the womb, causing debilitating ...